{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:18:08Z","timestamp":1788427088769,"version":"build-2803163510"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec><jats:title>Purpose of review<\/jats:title><jats:p>There has recently been renewed interest in the study of the various facets of familial hypercholesterolemia, a severe monogenic disease associated with elevated LDL-cholesterol and premature cardiovascular disease (CVD). In the present review, novel data presenting the frequency of familial hypercholesterolemia as well as factors modulating the cardiovascular risk in familial hypercholesterolemia will be discussed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent findings<\/jats:title><jats:p>Recent studies have showed that familial hypercholesterolemia is much more prevalent than initially thought. Classically, it was estimated that familial hypercholesterolemia affected one in 500 people worldwide, but a recent large-scale meta-analysis has shown a prevalence closer to one in 250. In the French-Canadian population, this disease is even more frequent reaching one in 81 in certain regions of the Province of Quebec. Several novel studies in the French-Canadian population have shown that the clinical outcomes in familial hypercholesterolemia seem to be greatly influenced by risk factors other than LDL-cholesterol. Also, scores to predict CVD in familial hypercholesterolemia have been recently proposed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>Familial hypercholesterolemia is more frequent than initially thought and the phenotype of this disease can be variable. Indeed, both clinical and genetic variables can modulate the CVD risk in this population.<\/jats:p><\/jats:sec>","DOI":"10.1097\/mol.0000000000000487","type":"journal-article","created":{"date-parts":[[2018,1,21]],"date-time":"2018-01-21T02:34:33Z","timestamp":1516502073000},"page":"59-64","source":"Crossref","is-referenced-by-count":29,"title":["Familial hypercholesterolemia: experience from the French-Canadian population"],"prefix":"10.1097","volume":"29","author":[{"given":"Martine","family":"Paquette","sequence":"first","affiliation":[{"name":"Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montr\u00e9al"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[{"name":"Division of cardiology, The McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[{"name":"Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montr\u00e9al"},{"name":"Division of Experimental Medicine"},{"name":"Division of Medical Biochemistry, Department of Medicine, McGill University, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"e016461","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ Open"},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"Hobbs","year":"1992","journal-title":"Hum Mutat"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.genom.2.1.69","article-title":"Human genetics: lessons from Quebec populations","volume":"2","author":"Scriver","year":"2001","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1399-0004.2005.00497.x","article-title":"Population history and its impact on medical genetics in Quebec","volume":"68","author":"Laberge","year":"2005","journal-title":"Clin Genet"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"6D","DOI":"10.1016\/0002-9149(93)90003-U","article-title":"Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a \u2018founder effect\u2019","volume":"72","author":"Davignon","year":"1993","journal-title":"Am J Cardiol"},{"key":"R6-20230917","first-page":"A216","article-title":"Familial hypercholesterolemia in French-Canadians: geographical distribution and centre of origin of an LDL-receptor deletion mutation","volume":"43","author":"Jomphe","year":"1988","journal-title":"Am J Hum Genet"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1096-8644(200101)114:1<30::AID-AJPA1003>3.0.CO;2-L","article-title":"Fragmentation of the Qu\u00e9bec population genetic pool (Canada): evidence from the genetic contribution of founders per region in the 17th and 18th centuries","volume":"114","author":"Gagnon","year":"2001","journal-title":"Am J Phys Anthropol"},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0021-9150(98)00267-6","article-title":"Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations","volume":"143","author":"Couture","year":"1999","journal-title":"Atherosclerosis"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF00219339","article-title":"Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians","volume":"88","author":"B\u00e9tard","year":"1992","journal-title":"Hum Genet"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.ATV.9.2.211","article-title":"Homozygous familial hypercholesterolemia among French Canadians in Qu\u00e9bec Province","volume":"9","author":"Moorjani","year":"1989","journal-title":"Arteriosclerosis"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM198709173171204","article-title":"Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia","volume":"317","author":"Hobbs","year":"1987","journal-title":"N Engl J Med"},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-0004.1989.tb03194.x","article-title":"Identification of a second \u2018French Canadian\u2019 LDL receptor gene deletion and development of a rapid method to detect both deletions","volume":"36","author":"Ma","year":"1989","journal-title":"Clin Genet"},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/hmg\/3.9.1689","article-title":"Detection of a novel mutation (stop 468) in exon 10 of the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians","volume":"3","author":"Simard","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"(Suppl 1)","key":"R14-20230917","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1002\/humu.1380110173","article-title":"Identification of three mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians","volume":"6","author":"Couture","year":"1998","journal-title":"Hum Mutat"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/(SICI)1098-1004(1997)9:6<555::AID-HUMU9>3.0.CO;2-0","article-title":"Identification of two novel LDL receptor gene defects in French-Canadian pediatric population: mutational analysis and biochemical studies","volume":"9","author":"Assouline","year":"1997","journal-title":"Hum Mutat"},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1172\/JCI114531","article-title":"Common low-density lipoprotein receptor mutations in the French Canadian population","volume":"85","author":"Leitersdorf","year":"1990","journal-title":"J Clin Invest"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.1997.tb02506.x","article-title":"Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of Quebec","volume":"52","author":"Vohl","year":"1997","journal-title":"Clin Genet"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cjca.2013.03.004","article-title":"Regional distribution and metabolic effect of PCSK9 insLEU and R46L gene mutations and apoE genotype","volume":"29","author":"Awan","year":"2013","journal-title":"Can J Cardiol"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1373\/clinchem.2014.225946","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9): lessons learned from patients with hypercholesterolemia","volume":"60","author":"Awan","year":"2014","journal-title":"Clin Chem"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cjca.2014.09.028","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia","volume":"30","author":"Genest","year":"2014","journal-title":"Can J Cardiol"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamacardio.2017.2289","article-title":"Simulation of lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease","volume":"2","author":"Cannon","year":"2017","journal-title":"JAMA Cardiol"},{"key":"R25-20230917","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MOL.0000000000000391","article-title":"Phenotype vs. genotype in severe familial hypercholesterolemia: what matters most for the clinician?","volume":"28","author":"Santos","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"R26-20230917","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"R27-20230917","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/2047487314533218","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"22","author":"Watts","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2016.10.004","article-title":"The Montreal-FH-SCORE: a new score to predict cardiovascular events in familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacl.2017.07.008","article-title":"Cardiovascular disease in familial hypercholesterolemia: validation and refinement of the Montreal-FH-SCORE","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","article-title":"Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)","volume":"135","author":"P\u00e9rez de Isla","year":"2017","journal-title":"Circulation"},{"key":"R31-20230917","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cjca.2017.02.001","article-title":"Aortic calcification progression in heterozygote familial hypercholesterolemia","volume":"33","author":"Al Kindi","year":"2017","journal-title":"Can J Cardiol"},{"key":"R32-20230917","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199404143301503","article-title":"Genetic susceptibility to death from coronary heart disease in a study of twins","volume":"330","author":"Marenberg","year":"1994","journal-title":"N Engl J Med"},{"key":"R33-20230917","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1000 genomesbased genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"R34-20230917","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/ATVBAHA.114.304406","article-title":"PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study","volume":"34","author":"Saavedra","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R35-20230917","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jacl.2015.08.005","article-title":"Familial hypercholesterolemia: PCSK9 InsLEU genetic variant and prediabetes\/diabetes risk","volume":"9","author":"Saavedra","year":"2015","journal-title":"J Clin Lipidol"},{"key":"R36-20230917","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jacl.2017.01.012","article-title":"The 9p21.3 locus and cardiovascular risk in familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"key":"R37-20230917","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cjca.2017.07.480","article-title":"Scavenger receptor LOX1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia","volume":"33","author":"Paquette","year":"2017","journal-title":"Can J Cardiol"},{"key":"R38-20230917","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacl.2017.03.019","article-title":"Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201804000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T16:57:00Z","timestamp":1719766620000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201804000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000487","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}